Media & Entertainment Series C Investors & VC Firms
230 firms in this list, with a median first check of $540K. 9 of them lead rounds. Generated from verified public data and updated continuously.
Blume Ventures
MumbaiSeed–Late Stage$50K – $300K
11 people
XTech Ventures
TokyoSeed–Growth$150K – $350K
6 people
Bedrock
Los AngelesSeries A–Late Stage$5M – $30M
8 people
Fundamentum
GurugramSeries B–Series C$10M – $25M
Audacity Venture Capital
CampbellPre-Seed–Late Stage
6 people
Atlantic Vantage Point
ParisSeed–Late Stage$1M – $20M
11 people
Export and Investment Fund
NordhavnPre-Seed–Growth$108K – $7.6M
11 people
Flashpoint Venture Capital
LondonSeed–Late Stage$1M – $15M
11 people
Gresham House Ventures
LondonSeed–Late Stage$1.3M – $25.4M
11 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$500K – $50M
11 people
Impact Fund Denmark
Copenhagen KSeed–Late Stage$2.2M – $70.2M
11 people
Innova Capital Sp. z o.o.
WarsawSeries A–Growth$27M – $43.2M
11 people
LDC
LondonSeries B–Growth$12.7M – $127M
11 people
Limburgse Reconversie Maatschappij
HasseltSeed–Late Stage$27K – $10.8M
11 people
Mindworks
Hong KongPre-Seed–Growth$1M – $5M
11 people
Oost NL
ApeldoornSeed–Late Stage$108K – $2.7M
11 people
Spire Capital Partners
New YorkSeries A–Growth$15M – $125M
11 people
Unilever Ventures
LondonSeed–Late Stage$540K – $10.8M
11 people
World Innovation Lab (WiL)
TokyoSeed–Late Stage$5M – $30M
11 people
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
11 people
Citi Ventures
New YorkSeed–Late Stage
10 people
Hallstone Ventures
Los AngelesSeed–Series C
6 people
Entrepreneur Venture
ParisSeed–Late Stage$2.2M – $10.8M
10 people
NVM Private Equity LLP
Newcastle upon TyneSeries A–Growth$12.7M – $25.4M
10 people
Related lists
Series C Investors & VC Firms (2384)Media & Entertainment Investors & VC Firms (802)Media & Entertainment Series A Investors & VC Firms (693)Media & Entertainment Seed Investors & VC Firms (676)Series C Investors & VC Firms in United States (609)SaaS Series C Investors & VC Firms (524)Enterprise Software Series C Investors & VC Firms (476)Healthtech Series C Investors & VC Firms (452)Series C Investors & VC Firms in Global (450)Biotech Series C Investors & VC Firms (400)
Data sourced from public filings and firms' own websites — see our methodology.















